Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Novo Nordisk Stock Just Popped

TheMotleyFool

0 0

Novo Nordisk (NYSE: NVO) stock, maker of the blockbuster GLP-1 agonist weight-loss drugs Ozempic and Wegovy, jumped a lucky 7% through 12:20 p.m. ET Tuesday after London's Financial Times reported local activist hedge fund Parvus Asset Management is building a stake.

Reportedly, Parvus is upping its stake to gain more influence in picking a new CEO for Novo.

Image source: Getty Images.

Source Fool.com

Like: 0

NVO

Share